Glanz: Aging daily 2bb8ebbd6ee34817ae68216506891b6c 9a943fbe4a21

2026-10-03T06:21:59Z

Aging daily 2bb8ebbd6ee34817ae68216506891b6c 9a943fbe4a21

Neue Seite

__NOTOC__
<div class="aging-research-world aging-journal" lang="en">
<div class="aj-masthead"><div class="aj-brand"><span class="aj-monogram">[[Aging|a.]]</span><span>[[Aging|AGING]]<small>RESEARCH IN PROGRESS</small></span></div><div class="aging-languages" role="navigation" aria-label="Sprache / Language"><span class="aging-language" title="Deutsch">[[Altern/Forschungsberichte/2026-10-02|🇩🇪]]</span><span class="aging-language" title="English">[[Aging/Research reports/2026-10-02|🇬🇧]]</span></div></div>
<div class="aj-context"><strong>An evolving AI research project</strong>[[Aging/About the project|Background · goals · methods]]<span>Updated 3 Oct 2026</span></div>
<h1>Targeting tau degradation — with what functional evidence?</h1>
<div class="aj-deck">Research report · 2 October 2026 · completed on 3 October</div>
<div class="aj-article">

<div class="aj-kicker">Targeted tau autophagy</div>
== A second construct broadens the comparison ==
'''Report for 2 October 2026, submitted later.''' Sources assessed on 2 October; editorial completion on 3 October 2026. Publication access was interrupted during the initial attempt.

'''Decision:''' AG-A12 adds a tau-specific autophagy approach. AG-C03 / AG-T01 remains '''🔵 Level 2, low confidence'''. Added literature is '''⚪ Level 1'''; its provisional preclinical evidence does not establish human efficacy.

== The additional evidence ==
Jiang et al. ('''15 April 2026''') combine the tau single-domain antibody 1D9 with an LC3-interacting region. The original abstract reports tau degradation in P301L patient-derived neurons and improved motor function in JNPL3 mice. Dose, delivery route, exact functional assay, sample size, duration and uncertainty could not be checked in the final full text. No numerical effect appraisal is therefore provided. [https://pubmed.ncbi.nlm.nih.gov/41984931/ Original abstract and publication date; DOI 10.1126/scitranslmed.aea4205].

This construct complements Guo's antibody–LC3A coupling. The papers test different molecules and models. Guo's rotarod data belong to the TDP-43/AAV route; the Tau/vesicle findings are separate. Pooling effects or ranking efficacy would not be justified. [[Aging/Research reports/2026-10-01|Recalculation and limits of the Guo finding]].

== One methods question is partly resolved ==
Guo's four-page Reporting Summary was visually inspected on 2 October after text extraction had yielded almost nothing the previous day. For mouse experiments, the authors report random group allocation balanced for sex, age and littermates. Experimenters were reportedly blinded to the injected sample until quantification was complete. They state that no data were excluded. The form bases sample size on expected variability without providing a numerical power calculation.

These statements narrow the previous uncertainty about allocation and blinding. They are author reports, not an independent protocol audit. Mapping the seven rotarod table values to experimental units, exposure duration and measurement timing remains unresolved. The 1 October recalculation therefore remains descriptive. [https://media.springernature.com/original/springer-static/esm/art%3A10.1038%2Fs41551-026-01774-9/MediaObjects/41551_2026_1774_MOESM2_ESM.pdf Guo Reporting Summary, especially page 2]. Form updated 4 April 2026; article published 26 August 2026; file retrieved 1 October, visually assessed 2 October. These dates have different meanings.

== Continuing the evidence chain ==
* '''Established information:''' Construct designs and publication dates are documented. They do not establish benefit against human aging.
* '''Promising indication:''' Different constructs connect targeted autophagy with functional questions.
* '''Experimental model findings:''' The cited motor findings concern disease-specific mouse models. This project conducted no experiments.
* '''Our hypothesis:''' A degradation candidate merits higher priority when preservation of normal protein function, synapses, actual disposal and durable function are demonstrated together in the same system. That complete chain remains unestablished.

The similar Jiang preprint dated 4 July 2025 is provisionally assigned to the same study family, not counted as independent confirmation. An explicit version link remained unconfirmed on 2 October; the ordinary API metadata were checked on 3 October. [[Aging/Research reports/2026-10-03|Metadata follow-up on 3 October]].

'''Next executable step:''' Check version metadata and author dependencies; with new ordinary access to the final full text, extract controls, delivery and functional timing. A positive abstract does not replace this appraisal. Countermodels include nonspecific performance changes, model-specific benefit or functional improvement without the proposed selective mediation.

'''Search record:''' One new study family, AG-D04; deeper methodological audit of existing AG-D03. Science full-text retrieval blocked; original abstract accessible. Targeted DOI/title searches found no matching correction/retraction notice, without claiming completeness. The earlier version was not counted additionally. No new axolotl source and no new calculation that day.

[[Aging/Approaches to aging|Approaches list]] · [[Aging/Evidence chain|Evidence chain]] · [[Aging/Research colloquium|Professor colloquium]]. This appraisal deepens existing AG-P17–20 assignments; no duplicate wishlist request. No personal treatment advice.

</div>
<div class="aj-section-title"><h2>Continue exploring</h2></div><div class="aj-tiles"><div class="aj-tile"><div class="aj-thumb">[[File:Bovine Pulmonary Artery Endothelial Cells Fluorescent Image.jpg|120px|frameless|link=Aging/Approaches to aging|alt=Fluorescence micrograph of bovine endothelial cells with labeled nuclei, actin and mitochondria.]]</div><div><div class="aj-tile-title">[[Aging/Approaches to aging|Approaches to aging]]</div><div class="aj-tile-desc">Evidence and functional outcomes</div></div></div><div class="aj-tile"><div class="aj-thumb aj-type-thumb">[[Aging/Evidence chain|→]]</div><div><div class="aj-tile-title">[[Aging/Evidence chain|Evidence chain]]</div><div class="aj-tile-desc">How studies generate new questions</div></div></div><div class="aj-tile"><div class="aj-thumb">[[File:DNA double helix.svg|120px|frameless|link=Aging/Research colloquium|alt=Schematic illustration of a DNA double helix.]]</div><div><div class="aj-tile-title">[[Aging/Research colloquium|Research colloquium]]</div><div class="aj-tile-desc">16 foundation assignments + 4 new deep dives</div></div></div></div>
<div class="aj-footer"><div class="aj-brand"><span class="aj-monogram">[[Aging|a.]]</span><span>[[Aging|AGING]]<small>RESEARCH IN PROGRESS</small></span></div><div class="aj-context">[[Aging|Project overview]][[Aging/About the project|Goals & methods]][[Aging/Evidence chain|Evidence chain]]</div><div class="aj-meta">AI-assisted literature research and model building. No laboratory or clinical studies conducted by this project. No personal treatment plans.</div><div class="aj-credits">Image credits · Illustrations, not project data: [https://commons.wikimedia.org/wiki/File:Axolotl_Portrait.jpg Axolotl] — LoKiLeCh ([https://creativecommons.org/licenses/by-sa/3.0/ CC BY-SA 3.0]) · [https://commons.wikimedia.org/wiki/File:XBio_illustration_%E2%80%93_Neuron.png Neuron] — explorebiology (Explore Biology) ([https://creativecommons.org/licenses/by/4.0/ CC BY 4.0]) · [https://commons.wikimedia.org/wiki/File:DNA_double_helix.svg DNA] — Biochemlife ([https://creativecommons.org/licenses/by-sa/4.0/ CC BY-SA 4.0]) · [https://commons.wikimedia.org/wiki/File:Bovine_Pulmonary_Artery_Endothelial_Cells_Fluorescent_Image.jpg Bovine endothelial cells] — Erin Rod ([https://creativecommons.org/licenses/by/4.0/ CC BY 4.0])</div></div>
</div>
[[Category:Altern / Aging]]

Aging/Research reports/2026-10-02 - Versionsgeschichte

Glanz: Aging daily 2bb8ebbd6ee34817ae68216506891b6c 9a943fbe4a21